Abstract
Background: Concussions (also known as mild traumatic brain injuries, MTBI) are common among adolescents, especially those who play sports. While often considered non-serious injuries, they can result in significant impairment in functioning. Neuropsychiatric symptoms, including cognitive impairment, behavioral dysfunction, and psychiatric disorders are among the most common sequelae.
Method: This article presents an overview of what is known at this point and makes recommendations regarding assessment and management.
Results: The knowledge base has expanded rapidly concerning risk factors, sequelae and neurobiology of MTBI. It is still underdeveloped regarding treatment, especially with regard to adolescents. Nonetheless, it is possible to extrapolate from the research on adults to develop a rational approach to management.
Conclusions: Key aspects of management include education and support for patients and families, teaching coping skills, and making academic accommodations. There is a limited role for psychopharmacologic approaches in conjunction with a comprehensive multidisciplinary approach. Most patients will recover but treatment must be individualized to address the patient’s specific problems and concerns.
Keywords: Concussion, traumatic brain injury, adolescents, sports injuries.
Adolescent Psychiatry
Title:Special Invited Article Concussion, Sports and Psychiatry
Volume: 3 Issue: 4
Author(s): Alexander S. Strauss
Affiliation:
Keywords: Concussion, traumatic brain injury, adolescents, sports injuries.
Abstract: Background: Concussions (also known as mild traumatic brain injuries, MTBI) are common among adolescents, especially those who play sports. While often considered non-serious injuries, they can result in significant impairment in functioning. Neuropsychiatric symptoms, including cognitive impairment, behavioral dysfunction, and psychiatric disorders are among the most common sequelae.
Method: This article presents an overview of what is known at this point and makes recommendations regarding assessment and management.
Results: The knowledge base has expanded rapidly concerning risk factors, sequelae and neurobiology of MTBI. It is still underdeveloped regarding treatment, especially with regard to adolescents. Nonetheless, it is possible to extrapolate from the research on adults to develop a rational approach to management.
Conclusions: Key aspects of management include education and support for patients and families, teaching coping skills, and making academic accommodations. There is a limited role for psychopharmacologic approaches in conjunction with a comprehensive multidisciplinary approach. Most patients will recover but treatment must be individualized to address the patient’s specific problems and concerns.
Export Options
About this article
Cite this article as:
Strauss S. Alexander, Special Invited Article Concussion, Sports and Psychiatry, Adolescent Psychiatry 2013; 3 (4) . https://dx.doi.org/10.2174/221067660304140121173447
DOI https://dx.doi.org/10.2174/221067660304140121173447 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypoxia-Inducible Factor-1 in Arterial Disease: A Putative Therapeutic Target
Current Vascular Pharmacology Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
Current Medicinal Chemistry - Anti-Cancer Agents Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo
Current Pharmaceutical Design Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments
Recent Patents on CNS Drug Discovery (Discontinued) Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-γ Ligand in Chronic Cerebral Hypoperfusion
Current Neurovascular Research Conference Report: (13th International Congress on Amino Acids, Peptides and Proteins (ICAPP); Neurobiology Symposium, October 5-7, 2013; Galveston TX, USA.)
CNS & Neurological Disorders - Drug Targets CEST MRI for Molecular Imaging of Brain Metabolites
Current Molecular Imaging (Discontinued) Editorial [Hot topic: Role of Inflammation in Neurological and Psychiatric Disorders (Guest Editor: Mohtashem Samsam)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Fish Oil Prevents Oxidative Stress and Exerts Sustained Antiamnesic Effect After Global Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Roles of miRNA in Cardiovascular Development and Dysfunction
Current Medicinal Chemistry Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management
Current Pharmaceutical Design Cerebral Hemorrhage Produced by Thrombolytic and Anti-Thrombotic Agents: A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Emerging Features in the Regulation of MMP-9 Gene Expression for the Development of Novel Molecular Targets and Therapeutic Strategies
Current Drug Targets - Inflammation & Allergy Targeting Metabolic Enzymes in Cancer – Clinical Trials Update
Current Enzyme Inhibition New Molecules as Drug Candidates for the Treatment of Upper and Lower GI Tract Ulcers
Current Pharmaceutical Design Intravenous Tranexamic Acid for Subdural and Epidural Intracranial Hemorrhage: Randomized, Double‐Blind, Placebo-Controlled Trial
Reviews on Recent Clinical Trials Recent Advances in Neuroinflammation Therapeutics: PPARs/LXR as Neuroinflammatory Modulators
Current Pharmaceutical Design Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Current Pharmaceutical Design Polyamine Modulation of NMDARs as a Mechanism to Reduce Effects of Alcohol Dependence
Recent Patents on CNS Drug Discovery (Discontinued) Redox Signaling Pathways Involved in Neuronal Ischemic Preconditioning
Current Neuropharmacology